Comparative Study
doi: 10.1016/j.fertnstert.2008.07.1711.
Epub 2008 Sep 6.
What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
Affiliations
- PMID: 18774558
- DOI: 10.1016/j.fertnstert.2008.07.1711
Item in Clipboard
Comparative Study
What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
Fertil Steril.
2009 Apr.
Free article
Abstract
In an attempt to evaluate the influence of the GnRH analogue used during controlled ovarian hyperstimulation (COH) on the outcome of IVF cycles of polycystic ovary syndrome (PCOS) patients, we studied 152 IVF cycles. The PCOS patients undergoing COH using the GnRH agonist protocol (n = 50) showed a significantly higher pregnancy rate (36% vs. 19.6%, respectively), compared with the GnRH antagonist protocol (n = 102).
Similar articles
-
GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.Fertil Steril. 2009 Apr;91(4 Suppl):1378-80. doi: 10.1016/j.fertnstert.2008.04.028. Epub 2008 Aug 3. Fertil Steril. 2009. PMID: 18675972
-
Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.Fertil Steril. 2009 Apr;91(4 Suppl):1398-400. doi: 10.1016/j.fertnstert.2008.04.064. Epub 2008 Aug 3. Fertil Steril. 2009. PMID: 18675974 Clinical Trial.
-
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25. Fertil Steril. 2009. PMID: 18367175
-
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.Reprod Biomed Online. 2006 Nov;13(5):628-38. doi: 10.1016/s1472-6483(10)60652-9. Reprod Biomed Online. 2006. PMID: 17169171
-
The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.Semin Reprod Med. 2001 Sep;19(3):213-20. doi: 10.1055/s-2001-18040. Semin Reprod Med. 2001. PMID: 11679902 Review.
Cited by
-
Treatment Outcome of Ovulation-inducing Agents in Patients with Anovulatory Infertility: A Prospective, Observational Study.J Pharmacol Pharmacother. 2017 Jul-Sep;8(3):116-121. doi: 10.4103/jpp.JPP_43_17. J Pharmacol Pharmacother. 2017. PMID: 29081619 Free PMC article.
-
Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries.Int J Endocrinol. 2012;2012:492803. doi: 10.1155/2012/492803. Epub 2012 Feb 28. Int J Endocrinol. 2012. PMID: 22518124 Free PMC article.
-
GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.Exp Ther Med. 2017 Jun;13(6):3097-3102. doi: 10.3892/etm.2017.4309. Epub 2017 Apr 5. Exp Ther Med. 2017. PMID: 28587385 Free PMC article.
-
Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179.J Assist Reprod Genet. 2012 Nov;29(11):1193-202. doi: 10.1007/s10815-012-9850-7. Epub 2012 Sep 8. J Assist Reprod Genet. 2012. PMID: 22960769 Free PMC article. Clinical Trial.
-
Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome.Med Sci Monit. 2018 Dec 28;24:9424-9428. doi: 10.12659/MSM.913757. Med Sci Monit. 2018. PMID: 30591703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
